Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor survival. The incidence and mortality of IPF are rising, but treatment remains limited. Currently, two drugs can slow the scarring process but often at the expense of intolerable side effects, and without sub...

Descripción completa

Detalles Bibliográficos
Autores principales: May, James, Mitchell, Jane A., Jenkins, R. Gisli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503802/
https://www.ncbi.nlm.nih.gov/pubmed/37712420
http://dx.doi.org/10.1172/JCI172058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503802/
https://www.ncbi.nlm.nih.gov/pubmed/37712420
http://dx.doi.org/10.1172/JCI172058

Ejemplares similares